Spyre Therapeutics
SYRE
SYRE
64 hedge funds and large institutions have $155M invested in Spyre Therapeutics in 2018 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+26
Holders Change %
+68.42%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
22
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$8.44M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.78M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5.39M |
| 4 |
Renaissance Technologies
New York
|
+$4.51M |
| 5 |
Millennium Management
New York
|
+$4.26M |
